Peter E Lipsky Selected Research

Peter E Lipsky Research Topics

Disease

38	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 05/2002
21	Gout 04/2024 - 08/2011
17	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 01/2003
15	Rheumatoid Arthritis 10/2023 - 01/2002
10	Inflammation (Inflammations) 01/2023 - 05/2004
6	Pain (Aches) 01/2023 - 03/2019
6	Arthritis (Polyarthritis) 05/2022 - 01/2008
4	Lupus Nephritis 01/2023 - 01/2003
4	Proteinuria 01/2021 - 11/2003
3	Neoplasms (Cancer) 04/2024 - 09/2007
3	Disease Progression 01/2023 - 01/2017
3	Body Weight (Weight, Body) 01/2019 - 10/2002
3	Infections 12/2018 - 06/2006
3	Immunoglobulin G4-Related Disease 11/2018 - 11/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2018 - 01/2006
2	Non-alcoholic Fatty Liver Disease 07/2023 - 01/2023
2	COVID-19 03/2023 - 01/2022
2	Autoimmune Hepatitis 01/2021 - 03/2006
2	Neutropenia 01/2021 - 02/2010
2	Vitamin D Deficiency 12/2018 - 08/2007
2	Communicable Diseases (Infectious Diseases) 01/2017 - 06/2008
2	Hypersensitivity (Allergy) 01/2017 - 05/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2012 - 02/2009
2	Rheumatic Diseases (Rheumatism) 01/2011 - 01/2006
2	Nephritis 06/2008 - 01/2006
2	Granuloma 06/2006 - 05/2004
2	Systemic Mastocytosis 06/2005 - 07/2002
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2023
1	Fatty Liver 07/2023
1	Lymphopenia (Lymphocytopenia) 03/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Gastroesophageal Reflux (GERD) 04/2022
1	Gouty Arthritis 11/2019

Drug/Important Bio-Agent (IBA)

15	AutoantibodiesIBA 01/2023 - 01/2003
13	Pegloticase FDA Link 01/2023 - 08/2011
13	Uric Acid (Urate)IBA 01/2023 - 08/2011
10	CytokinesIBA 03/2023 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 03/2023 - 06/2004
6	Antinuclear AntibodiesIBA 10/2020 - 01/2017
5	InterferonsIBA 01/2023 - 01/2019
5	AutoantigensIBA 01/2020 - 01/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2002
4	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2004
4	Urate Oxidase (Uricase)IBA 01/2020 - 03/2014
4	Methotrexate (Mexate)FDA LinkGeneric 10/2018 - 09/2014
4	AntibodiesIBA 03/2014 - 08/2006
3	Nucleic AcidsIBA 01/2023 - 01/2010
3	anti-dsDNA autoantibodyIBA 01/2021 - 01/2006
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2019 - 03/2014
3	Messenger RNA (mRNA)IBA 11/2018 - 05/2002
3	interleukin-21 (interleukin 21)IBA 11/2018 - 11/2004
3	Immunoglobulin G (IgG)IBA 11/2018 - 01/2006
3	ChemokinesIBA 01/2009 - 01/2003
2	Anthocyanins (Anthocyanin)IBA 01/2023 - 07/2022
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2019
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 10/2018
2	Peptides (Polypeptides)IBA 01/2021 - 01/2008
2	Syk KinaseIBA 01/2020 - 12/2014
2	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 08/2011
2	GlucocorticoidsIBA 02/2017 - 11/2015
2	MicroRNAs (MicroRNA)IBA 12/2010 - 05/2009
2	tocilizumab (atlizumab)FDA Link 02/2010 - 01/2006
2	triptolideIBA 06/2008 - 03/2007
2	DiterpenesIBA 06/2008 - 03/2007
2	NF-kappa B (NF-kB)IBA 01/2008 - 01/2004
2	Immunoglobulins (Immunoglobulin)IBA 03/2006 - 01/2003
1	Interleukin-1 (Interleukin 1)IBA 04/2024
1	Tumor Necrosis Factor InhibitorsIBA 10/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 09/2023
1	Transaminases (Aminotransferases)IBA 07/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	canakinumab FDA Link 01/2023
1	rilonacept FDA Link 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	Interferon Type IIBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Vitamin A (Retinol)FDA LinkGeneric 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	iberdomideIBA 04/2022
1	Opioid Analgesics (Opioids)IBA 04/2022
1	CateninsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Colchicine FDA LinkGeneric 09/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2020
1	Vancomycin FDA LinkGeneric 01/2020
1	Bacterial DNAIBA 01/2020
1	Febuxostat FDA Link 01/2020

Therapy/Procedure

14	Therapeutics 04/2024 - 01/2002
2	Aftercare (After-Treatment) 01/2006 - 11/2003
1	Intra-Articular Injections 07/2022
1	Oral Administration 07/2022
1	Drug Therapy (Chemotherapy) 04/2022
1	Cell Transplantation 01/2022
1	Precision Medicine 11/2021